Fiera Capital (Europe)’s Regeneron Pharmaceuticals REGN Stock Holding History

Fiera Capital (Europe)’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-263	Closed	-$143K	–	43
2015 Q4	$143K	Sell	263 -78	-23%	-$42.3K	0.17%	41
2015 Q3	$158K	Hold	341	–	–	0.21%	37
2015 Q2	$174K	Hold	341	–	–	0.16%	36
2015 Q1	$155K	Sell	341 -1,228	-78%	-$520K	0.14%	37
2014 Q4	$182K	Buy	1,569 +1,464	+1,394%	+$576K	0.13%	35
2014 Q3	$38K	Hold	105	–	–	0.03%	57
2014 Q2	$30K	Sell	105 -128	-55%	-$37.9K	0.02%	56
2014 Q1	$70K	Sell	233 -92	-28%	-$28.3K	0.05%	43
2013 Q4	$90K	Buy	+325	New	+$93.5K	0.05%	36

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fiera Capital (Europe)'s REGN Position: Q1 2016 in Review

Fiera Capital (Europe) sold out of Regeneron Pharmaceuticals (REGN) in Q1 2016, closing a stake of 263 shares — an estimated $143K sold.

Fiera Capital (Europe) first reported a position in REGN in Q4 2013 and held it in 9 quarters. The position peaked at $182K in Q4 2014. 550 funds tracked by Wall St. Rank hold REGN as of Q1 2016.

Fiera Capital (Europe) reported no remaining Regeneron Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
Fiera Capital (Europe) sold 263 Regeneron Pharmaceuticals shares in Q1 2016, an estimated $143K.
Fiera Capital (Europe) first reported a position in Regeneron Pharmaceuticals in Q4 2013 and held it in 9 quarters.
Fiera Capital (Europe)'s Regeneron Pharmaceuticals position peaked at $182K in Q4 2014.
550 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2016.

Based on Fiera Capital (Europe)'s 13F filing for Q1 2016, filed 5 May 2016.